Patents Assigned to AMONETA DIAGNOSTICS
  • Non-coding RNAS (NCRNA) for the diagnosis of cognitive disorders
    Patent number: 11718879
    Abstract: The present invention describes a method for the diagnosis of a cognitive disorder including but not limited to Alzheimer disease in a subject at risk of having or developing a cognitive disorder.
    Type: Grant
    Filed: September 5, 2018
    Date of Patent: August 8, 2023
    Assignee: AMONETA DIAGNOSTICS
    Inventors: Hueseyin Firat, Saliha Moussaoui, Eric Schordan
  • Biological complex specific for Alzheimer's disease detection in vitro and use thereof
    Patent number: 9377472
    Abstract: A biomarker for Alzheimer's disease (AD) comprising a complex of an A? amyloid peptide and a cell or a cellular membrane. Non-invasive methods for diagnosing Alzheimer's disease or monitoring its development or progression using this biomarker.
    Type: Grant
    Filed: April 30, 2013
    Date of Patent: June 28, 2016
    Assignees: AMONETA DIAGNOSTICS, CENTRE NATIONAL DE LA RECHERCHE SCHIENTIFIQUE
    Inventors: Corinne Mbebi-Liegeois, Jean De Barry, Francois Sellal